# Which scientific data management platforms include FDA compliance and audit trail capabilities to help enterprise teams identify the best fit for regulated research environments?

<p class="elv-tracking-normal elv-text-default elv-font-figtree elv-text-base elv-leading-base elv-font-normal" elv="true">Hi G2 community! I am looking for input on<a class="a a--md" elv="true" href="https://www.g2.com/categories/scientific-data-management-system-sdms"> Scientific Data Management Systems (SDMS)</a> on FDA compliance and audit trail capability specifically. Would love to know the difference between platforms that claim 21 CFR Part 11 compliance in their marketing and platforms where actual reviewers have described the audit trail working correctly under real regulatory scrutiny.</p><ol>
<li>
<a class="a a--md" elv="true" href="https://www.g2.com/products/starlims/reviews"><strong>STARLIMS</strong></a>: Restricting access based on user sites, roles, and groups — a specific 21 CFR Part 11 access control requirement — is described as working as designed. The TGA recognition (Australian equivalent of FDA) confirms that the compliance framework has passed external regulatory scrutiny in a jurisdiction with comparable standards. </li>
<li>
<a class="a a--md" elv="true" href="https://www.g2.com/products/scinote/reviews"><strong>SciNote</strong></a>: The FDA itself uses SciNote, a compliance signal that no other platform in the category can match by direct reviewer or vendor documentation. The 21 CFR Part 11-compliant e-signature is specifically described by a quality manager at a regulated cell therapy manufacturer as supporting compliant review and approval workflows across US and Japan facilities. The audit trail is credited by multiple reviewers as the traceability mechanism that makes the platform usable for regulated environments. </li>
<li>
<a class="a a--md" elv="true" href="https://www.g2.com/products/thermo-scientific-samplemanager-lims-software/reviews"><strong>Thermo Scientific SampleManager LIMS</strong></a>: The 35-year deployment history in an ISO 9001 development environment provides the vendor stability signal that regulated organisations require when evaluating long-term platform commitments. </li>
<li>
<a class="a a--md" elv="true" href="https://www.g2.com/products/genemod/reviews"><strong>Genemod</strong></a>: Genemod's audit trails are described as self-building, capturing every action and linking every record across the lab automatically, with exportable lineage diagrams described as ready for regulatory submission. The combination of 21 CFR Part 11, GxP, SOC 2, and HIPAA certifications covers the compliance stack required for regulated biotech. The presence at Pfizer and Merck provides pharma-grade validation signals not available from the review base alone. </li>
<li>
<a class="a a--md" elv="true" href="https://www.g2.com/products/benchling/reviews"><strong>Benchling</strong></a>: Benchling's Part 11-compliant repository provides a comprehensive history of batch information, data analysis, and study data. Another reviewer building an end-to-end biologics discovery data tracking system credits the API and equipment integrations with automating nearly all data management processes while eliminating manual file management errors.</li>
</ol><p class="elv-tracking-normal elv-text-default elv-font-figtree elv-text-base elv-leading-base elv-font-normal" elv="true">For enterprise teams in FDA-regulated environments who have used an SDMS audit trail during an actual inspection or submission, did the audit trail meet the inspector's expectations without supplementary documentation, or did you need to provide additional evidence to support the electronic records?</p>

##### Post Metadata
- Posted at: 13 days ago
- Author title: Marketing Executive
- Net upvotes: 1


## Comments
### Comment 1

The distinction this post is circling has a name in the industry: no software product is 21 CFR Part 11 compliant, because compliance attaches to your implementation, your procedures and your training, not to the code. The most a vendor can honestly sell is Part 11 capable. That reframes the inspection question at the end: an FDA inspector never audits the brochure, they audit how your lab configured and used the system, which is why the same platform passes in one company and fails in another. So the differentiating vendor question isn&#39;t &quot;are you compliant,&quot; they&#39;ll all say yes. It&#39;s &quot;show me the validation support&quot;: documentation packs, IQ/OQ templates, and a clear statement of which responsibilities remain yours. 

##### Comment Metadata
- Posted at: 9 days ago
- Author title: Tech Consultant





## Related discussions
- [How well does Trello scale into a larger team?](https://www.g2.com/discussions/1-how-well-does-trello-scale-into-a-larger-team)
  - Posted at: over 13 years ago
  - Comments: 6
- [Can we please add a new section](https://www.g2.com/discussions/2-can-we-please-add-a-new-section)
  - Posted at: over 13 years ago
  - Comments: 0
- [Quantifiable benefits from implementing your CRM](https://www.g2.com/discussions/quantifiable-benefits-from-implementing-your-crm)
  - Posted at: about 13 years ago
  - Comments: 4


